Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
28.36
-0.50 (-1.73%)
At close: Dec 8, 2025, 4:00 PM EST
28.54
+0.18 (0.63%)
Pre-market: Dec 9, 2025, 8:46 AM EST
Caris Life Sciences Stock Forecast
Stock Price Forecast
The 7 analysts that cover Caris Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $34.43, which forecasts a 21.40% increase in the stock price over the next year. The lowest target is $28 and the highest is $42.
Price Target: $34.43 (+21.40%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Caris Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Initiates $28 | Hold | Initiates | $28 | -1.27% | Dec 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $32 → $36 | Strong Buy | Maintains | $32 → $36 | +26.94% | Aug 13, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $33 → $40 | Buy | Maintains | $33 → $40 | +41.04% | Aug 13, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $34 → $42 | Strong Buy | Maintains | $34 → $42 | +48.10% | Aug 13, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $33 | Buy | Initiates | $33 | +16.36% | Jul 15, 2025 |
Financial Forecast
Revenue This Year
732.54M
from 412.26M
Increased by 77.69%
Revenue Next Year
994.77M
from 732.54M
Increased by 35.80%
EPS This Year
-2.51
from -10.66
EPS Next Year
0.27
from -2.51
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 768.6M | 1.1B | |||
| Avg | 732.5M | 994.8M | |||
| Low | 707.6M | 913.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.4% | 46.1% | |||
| Avg | 77.7% | 35.8% | |||
| Low | 71.6% | 24.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.69 | 0.48 | |||
| Avg | -2.51 | 0.27 | |||
| Low | -8.22 | 0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.